The insula: a critical neural substrate for craving and drug seeking under conflict and risk

Drug addiction is characterized by the inability to control drug use when it results in negative consequences or conflicts with more adaptive goals. Our previous work showed that damage to the insula disrupted addiction to cigarette smoking—the first time that the insula was shown to be a critical n...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the New York Academy of Sciences Vol. 1316; no. 1; pp. 53 - 70
Main Authors Naqvi, Nasir H., Gaznick, Natassia, Tranel, Daniel, Bechara, Antoine
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.05.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0077-8923
1749-6632
1749-6632
DOI10.1111/nyas.12415

Cover

More Information
Summary:Drug addiction is characterized by the inability to control drug use when it results in negative consequences or conflicts with more adaptive goals. Our previous work showed that damage to the insula disrupted addiction to cigarette smoking—the first time that the insula was shown to be a critical neural substrate for addiction. Here, we review those findings, as well as more recent studies that corroborate and extend them, demonstrating the role of the insula in (1) incentive motivational processes that drive addictive behavior, (2) control processes that moderate or inhibit addictive behavior, and (3) interoceptive processes that represent bodily states associated with drug use. We then describe a theoretical framework that attempts to integrate these seemingly disparate findings. In this framework, the insula functions in the recall of interoceptive drug effects during craving and drug seeking under specific conditions where drug taking is perceived as risky and/or where there is conflict between drug taking and more adaptive goals. We describe this framework in an evolutionary context and discuss its implications for understanding the mechanisms of behavior change in addiction treatments.
Bibliography:ArticleID:NYAS12415
NIDA - No. R01 DA16708; No. T32 DA007294
Leon Levy Foundation
istex:8C8F95F56B54581BE63C285D5E9399B9FE6DC018
ark:/67375/WNG-6PG566ZZ-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0077-8923
1749-6632
1749-6632
DOI:10.1111/nyas.12415